BC
VXRT

Broadfin Capital’s Vaxart VXRT Stock Holding History

Broadfin Capital’s Portfolio VXRT Stock Details VXRT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q2 		– Sell
-289,021
Closed -$2.07M – 59
2017
Q1 		$2.07M Sell
289,021
-27,953
-9% -$286K 0.25% 47
2016
Q4 		$4.29M Hold
316,974
– – 0.48% 47
2016
Q3 		$6.69M Hold
316,974
– – 0.6% 45
2016
Q2 		$4.88M Hold
316,974
– – 0.47% 48
2016
Q1 		$5.23M Hold
316,974
– – 0.51% 49
2015
Q4 		$6.76M Hold
316,974
– – 0.42% 58
2015
Q3 		$6.9M Buy
316,974
+79,546
+34% +$1.93M 0.38% 60
2015
Q2 		$5.41M Hold
237,428
– – 0.29% 72
2015
Q1 		$6.01M Hold
237,428
– – 0.47% 55
2014
Q4 		$5.85M Hold
237,428
– – 0.51% 46
2014
Q3 		$6.45M Buy
237,428
+135,416
+133% +$3.88M 0.68% 44
2014
Q2 		$3.2M Buy
102,012
+44,130
+76% +$1.84M 0.31% 61
2014
Q1 		$3.89M Buy
+57,882
New +$3.58M 0.38% 61

Other funds holding VXRT

KAM
Krensavage Asset Management New York $263M AUM 66.99% 1-Year Est. Return
AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
GCIA
Gabelli & Co Investment Advisers Rye, New York $688M AUM 63.39% 1-Year Est. Return
VKH
Virtu KCG Holdings New York $3.6B AUM 17.11% 1-Year Est. Return
BCM
Bridgeway Capital Management Houston, Texas $5.69B AUM 60.64% 1-Year Est. Return
TL
TowerView LLC New York $152M AUM 20.28% 1-Year Est. Return

Broadfin Capital's VXRT Position: Q2 2017 in Review

Broadfin Capital sold out of Vaxart (VXRT) in Q2 2017, closing a stake of 289,021 shares — an estimated $2.07M sold.

Broadfin Capital first reported a position in VXRT in Q1 2014 and held it in 13 quarters. The position peaked at $6.9M in Q3 2015. 32 funds tracked by Wall St. Rank hold VXRT as of Q2 2017.

  • Broadfin Capital reported no remaining Vaxart position as of Q2 2017 after selling out during the quarter.
  • Broadfin Capital sold 289,021 Vaxart shares in Q2 2017, an estimated $2.07M.
  • Broadfin Capital first reported a position in Vaxart in Q1 2014 and held it in 13 quarters.
  • Broadfin Capital's Vaxart position peaked at $6.9M in Q3 2015.
  • 32 funds tracked by Wall St. Rank held Vaxart as of Q2 2017.

Based on Broadfin Capital's 13F filing for Q2 2017, filed 14 Aug 2017.